Nucleated red blood cells are a direct response to mediators of inflammation in newborns with early-onset neonatal sepsis.
OBJECTIVE
The objective of the study was to test the hypothesis that inflammation modulates fetal erythroblastosis and/or the release of nucleated red blood cells (NRBCs) independent of hypoxia or fetal stress. We sought to determine whether fetal inflammation is associated with an elevation in neonatal NRBC count in the setting of inflammation-associated preterm birth.


METHODS
The relationships between peripheral NRBC count, histological chorioamnionitis, umbilical cord interleukin (IL)-6, erythropoietin (EPO), cortisol, and acid-base status were analyzed in 68 preterm singletons, born to mothers who had an amniocentesis to rule out infection. Proteomic profiling of amniotic fluid identified presence of intraamniotic inflammation according to established parameters. NRBC counts were assessed within 1 hour of birth. Early-onset neonatal sepsis (EONS) was established based on hematological and microbiological indices. IL-6, EPO, and cortisol levels were measured by immunoassays. Fetal acid-base status was determined within 10 minutes of delivery. Parametric or nonparametric statistics were used.


RESULTS
Fetuses with EONS (n = 19) were delivered at earlier gestational ages (mean +/- SD: 27.1 +/- 2.8 weeks, P = .001) and more often by mothers with intraamniotic inflammation (P = .022) and histological chorioamnionitis (P < .001). Neonates with EONS had higher absolute NRBC counts (P = .011). NRBC counts were directly correlated with cord blood IL-6 levels (P < .001) but not with EPO, cortisol or parameters of acid-base status levels regardless of EONS status. These relationships remained following correction for gestational age, diabetes, intrauterine growth restriction, and steroid exposure.


CONCLUSIONS
In the setting of inflammation-associated preterm birth and in the absence of hypoxia, elevations in NRBCs in the early neonatal period may be a direct response of exposure to inflammatory mediators in utero.
Dulay
Antonette T
AT
Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520-8063, USA. antonette.dulay@yale.edu
Buhimschi
Irina A
IA
Zhao
Guomao
G
Luo
Guoyang
G
Abdel-Razeq
Sonya
S
Cackovic
Michael
M
Rosenberg
Victor A
VA
Pettker
Christian M
CM
Thung
Stephen F
SF
Bahtiyar
Mert O
MO
Bhandari
Vineet
V
Buhimschi
Catalin S
CS
D000328:Adult; D002821:Chorioamnionitis / Q000097:blood / Q000276:immunology*; D004899:Erythroblastosis, Fetal / Q000097:blood / Q000276:immunology; D004900:Erythroblasts / Q000378:metabolism*; D004906:Erythrocyte Count; D005260:Female; D005316:Fetal Distress / Q000097:blood*; D006801:Humans; D000860:Hypoxia / Q000097:blood / Q000276:immunology; D007231:Infant, Newborn; D018836:Inflammation Mediators; D008297:Male; D011247:Pregnancy; D047928:Premature Birth / Q000097:blood / Q000276:immunology*; D018805:Sepsis / Q000097:blood / Q000276:immunology*
D018836:Inflammation Mediators